Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VLA2001 phase I/II COVID-19 vaccine dose-escalation and dose-comparison study
ISRCTN82411169Phase 2Completed
- Sponsor
- Valneva
- Start
- Dec 2020
- Modality
- Whole Inactivated Vaccines → Inactivated Vaccines → Prophylactic Vaccines → Vaccines & Immunotherapeutics, Viral Vector Vaccines → Recombinant Vaccines → Prophylactic Vaccines → Vaccines & Immunotherapeutics
01
Overview
Phase 2 trial of VLA2001, sponsored by Valneva. Started Dec 2020; status: completed.
02
Drugs
VLA2001
Beyond the preview
Go deeper on ISRCTN82411169.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN82411169.